<DOC>
	<DOC>NCT00297765</DOC>
	<brief_summary>A study to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients.</brief_summary>
	<brief_title>Optimizing Prograf® Therapy in Renal Transplant Patients</brief_title>
	<detailed_description>A 3 arm study (2 Active, 1 Active Control) to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patient was 18 years of age at the time of transplant. Patient is at least 6 months posttransplant. Patient is the recipient of a solid organ transplant other than the kidney. Patient is a known carrier of any of the HIV viruses.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Renal Transplantation</keyword>
	<keyword>Therapeutics</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Safety</keyword>
</DOC>